IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS
Emmanuelle Waubant(University of California, San Francisco), David Leppert, Alan Bostrom(University of California, San Francisco), Jack Hietpas(Rockefeller University), D Goodkin(The Stables), Raija L.P. Lindberg, Peter Bacchetti(University of California, San Francisco)
Cited by 104
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Age Affects Outcomes in Chronic Kidney Disease
|Journal of the American Society of Nephrology|2007|749